Inclusion Criteria:
  -  Male and female patients with a diagnosis of SJIA as per the International League of Associations for Rheumatology (ILAR) classification criteria
  -  Included in the Pharmachild registry
  -  Ever treated with Kineret subsequently to SJIA diagnosis
Exclusion Criteria:
No specific exclusion criteria will be applied.